Stay updated on Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:28:02.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T19:39:39.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error rather than a clinical trial record.
    Difference
    0.2%
    Check dated 2026-10-10T20:19:06.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the study details with a minimal error page and a site footer.
    Difference
    21%
    Check dated 2026-09-19T19:12:26.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page shows a revision label update from v3.6.5 to v3.6.6, indicating a new version of the page was released.
    Difference
    0.0%
    Check dated 2026-08-29T19:29:18.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This indicates a small deployment update to the page framework, with no changes to the study details or other visible content.
    Difference
    0.0%
    Check dated 2026-08-08T20:03:09.000Z thumbnail image

Stay in the know with updates to Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.